SANOFI $53.52

down -1.04


19/6/2013 03:19 PM  |  NYSE : SNY  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 53.52
Trade Time: Jun 19 3:19 PM Eastern Daylight Time
Change: -1.04 (-1.91 %)
Prev Close: 54.56
Open: 54.45
Bid: 53.52
Ask: 53.54
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get SNY Trend Analysis - it has outperformed the S&P 500 by 29%

ETF Alternatives



People viewing SNY also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ACEL TAMIR BIOTECHNOLOGY 5.5K +1.50%
CKGT CHINA KANGTAI CACTUS BIO 500.0 +1.11%
GNTAQ GENTA 1.5M +1.00%
CNSO CNS RESPONSE 100.0 +0.65%
TRGM TARGETED MEDICAL PHARMA 34.1K +0.56%

SNY Stock Analysis

  1. Good News for InterMune - Analyst Blog

    The pricing and reimbursement conditions for InterMune's Esbriet was approved in Italy.
  2. Sanofi's Fluzone Quadrivalent Gets FDA Nod - Analyst Blog

    Sanofi announced that the FDA has cleared its quadrivalent formulation of Fluzone
  3. CHMP Positive on Sanofi's Lantus - Analyst Blog

    The Committee for Medicinal Products for Human Use issued a positive opinion related to Lantus
  4. Glaxo Reports Disappointing Tykerb Data - Analyst Blog

    GlaxoSmithKline announced disappointing data from a global phase III study evaluating the use of Tykerb
  5. Top-Performing Dividend Payers in Health Care with the Most Upside Potential (AET, ENSG, QCOR)

    It is not unusual for stocks on a tear to overrun their mean price targets, which is a signal of how far analysts on average expect the share price to climb. Some of the top-performing health care stocks over the past six months that pay dividends, such as Becton, Dickinson (NYSE: COO), have done just that.
  6. FDA Panel Positive on GSK's Avandia - Analyst Blog

    The FDA panel recently voted in favor of easing safety restrictions related to Glaxo's Avandia.
Free Reports
  1. Find the Best Mortgage Rates

    Search and compare the best fixed and adjustable mortgage rates in your area with Bankrate.com.
  2. 3 Stocks Peter Lynch Would Buy Today

    This new special report identifies 3 stocks based on Lynch’s market-trouncing strategy that could more than double in the next 12 months.
  3. Free Managed Futures Book

    Get the four benefits of managed futures as outlined in this booklet.
Marketplace
Trading Center